# Activation Innate Immune System in Type 1 Diabetes

> **NCT03441919** · — · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 66 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1
- Cardiovascular Diseases
- Innate Immune System
- Inflammation
- Metabolism Disorder, Glucose

## Interventions

- **RADIATION:** PET-CT (positron emission tomography - computer tomography)
- **DIAGNOSTIC_TEST:** Blood drawn

## Key facts

- **NCT ID:** NCT03441919
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-18
- **Primary completion:** 2019-01-21
- **Final completion:** 2019-01-21
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2019-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03441919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03441919, "Activation Innate Immune System in Type 1 Diabetes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03441919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*